{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:23:32Z","timestamp":1791501812776,"version":"4.3.4"},"reference-count":49,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Med Report"],"DOI":"10.3892\/mmr.2019.10352","type":"journal-article","created":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T06:50:01Z","timestamp":1559803801000},"source":"Crossref","is-referenced-by-count":8,"title":["Interleukin\u201112 exacerbates Sj\ufffdgren's syndrome through induction of myeloid\u2011derived suppressor cells"],"prefix":"10.3892","author":[{"given":"Jingjing","family":"Qi","sequence":"first","affiliation":[{"name":"The State Key Laboratory of Pharmaceutical Biotechnology, Division of Immunology, Medical School, Nanjing University, Nanjing, Jiangsu 210093, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[{"name":"The State Key Laboratory of Pharmaceutical Biotechnology, Division of Immunology, Medical School, Nanjing University, Nanjing, Jiangsu 210093, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoping","family":"Shi","sequence":"additional","affiliation":[{"name":"The State Key Laboratory of Pharmaceutical Biotechnology, Division of Immunology, Medical School, Nanjing University, Nanjing, Jiangsu 210093, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefang","family":"Zhang","sequence":"additional","affiliation":[{"name":"The State Key Laboratory of Pharmaceutical Biotechnology, Division of Immunology, Medical School, Nanjing University, Nanjing, Jiangsu 210093, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Pan","sequence":"additional","affiliation":[{"name":"The State Key Laboratory of Pharmaceutical Biotechnology, Division of Immunology, Medical School, Nanjing University, Nanjing, Jiangsu 210093, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Dou","sequence":"additional","affiliation":[{"name":"The State Key Laboratory of Pharmaceutical Biotechnology, Division of Immunology, Medical School, Nanjing University, Nanjing, Jiangsu 210093, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Wang","sequence":"additional","affiliation":[{"name":"The State Key Laboratory of Pharmaceutical Biotechnology, Division of Immunology, Medical School, Nanjing University, Nanjing, Jiangsu 210093, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genhong","family":"Yao","sequence":"additional","affiliation":[{"name":"The State Key Laboratory of Pharmaceutical Biotechnology, Division of Immunology, Medical School, Nanjing University, Nanjing, Jiangsu 210093, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yayi","family":"Hou","sequence":"additional","affiliation":[{"name":"The State Key Laboratory of Pharmaceutical Biotechnology, Division of Immunology, Medical School, Nanjing University, Nanjing, Jiangsu 210093, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2019,6,6]]},"reference":[{"key":"key20200713233149_b1-mmr-20-02-1131","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1080\/08916930410001708715","article-title":"Sjogren's syndrome","volume":"37","author":"Soliotis","year":"2004","journal-title":"Autoimmunity"},{"key":"key20200713233149_b2-mmr-20-02-1131","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.intimp.2016.08.006","article-title":"Clinical and immunological consequences of total glucosides of paeony treatment in Sj\u00f6gren's syndrome: A randomized controlled pilot trial","volume":"39","author":"Zhou","year":"2016","journal-title":"Int Immunopharmacol"},{"key":"key20200713233149_b3-mmr-20-02-1131","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1146\/annurev-pathol-012513-104728","article-title":"Sj\u00f6gren's syndrome","volume":"9","author":"Mavragani","year":"2014","journal-title":"Annu Rev Pathol"},{"key":"key20200713233149_b4-mmr-20-02-1131","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.1182\/blood-2011-11-391144","article-title":"Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sj\u00f6gren syndrome","volume":"120","author":"Xu","year":"2012","journal-title":"Blood"},{"key":"key20200713233149_b5-mmr-20-02-1131","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jaut.2012.01.002","article-title":"Pathogenesis of Sj\u00f6gren's syndrome: What we know and what we should learn","volume":"39","author":"Tzioufas","year":"2012","journal-title":"J Autoimmun"},{"key":"key20200713233149_b6-mmr-20-02-1131","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1365-2249.2012.04587.x","article-title":"Cytokine\/chemokine profiles contribute to understanding the pathogenesis and diagnosis of primary Sj\u00f6gren's syndrome","volume":"169","author":"Moriyama","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"key20200713233149_b7-mmr-20-02-1131","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1146\/annurev-med-043015-123313","article-title":"Mechanisms and new strategies for primary Sj\u00f6gren's syndrome","volume":"68","author":"Mavragani","year":"2017","journal-title":"Annu Rev Med"},{"key":"key20200713233149_b8-mmr-20-02-1131","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1136\/ard.2009.115378","article-title":"Cytokines in Sjogren's syndrome: Potential therapeutic targets","volume":"69","author":"Roescher","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"key20200713233149_b9-mmr-20-02-1131","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/ni.2366","article-title":"IL-12 family cytokines: Immunological playmakers","volume":"13","author":"Vignali","year":"2012","journal-title":"Nat Immunol"},{"key":"key20200713233149_b10-mmr-20-02-1131","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1146\/annurev.immunol.22.012703.104758","article-title":"Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation","volume":"25","author":"Kastelein","year":"2007","journal-title":"Annu Rev Immunol"},{"key":"key20200713233149_b11-mmr-20-02-1131","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1002\/art.27318","article-title":"Increased expression of interleukin-7 in labial salivary glands of patients with primary Sj\u00f6gren's syndrome correlates with increased inflammation","volume":"62","author":"Bikker","year":"2010","journal-title":"Arthritis Rheum"},{"key":"key20200713233149_b12-mmr-20-02-1131","doi-asserted-by":"publisher","first-page":"3977","DOI":"10.1002\/art.23073","article-title":"Rates of infiltration by macrophages and dendritic cells and expression of interleukin-18 and interleukin-12 in the chronic inflammatory lesions of Sj\u00f6gren's syndrome: Correlation with certain features of immune hyperactivity and factors associated with high risk of lymphoma development","volume":"56","author":"Manoussakis","year":"2007","journal-title":"Arthritis Rheum"},{"key":"key20200713233149_b13-mmr-20-02-1131","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3109\/08916939608995349","article-title":"Cytokine gene expression and autoantibody production in Sj\u00f6gren's syndrome of MRL\/lpr mice","volume":"23","author":"Hayashi","year":"1996","journal-title":"Autoimmunity"},{"key":"key20200713233149_b14-mmr-20-02-1131","doi-asserted-by":"publisher","first-page":"3633","DOI":"10.1002\/art.24980","article-title":"Interleukin-12 induces salivary gland dysfunction in transgenic mice, providing a new model of Sj\u00f6gren's syndrome","volume":"60","author":"Vosters","year":"2009","journal-title":"Arthritis Rheum"},{"key":"key20200713233149_b15-mmr-20-02-1131","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/nm.3895","article-title":"IL-12 and IL-23 cytokines: From discovery to targeted therapies for immune-mediated inflammatory diseases","volume":"21","author":"Teng","year":"2015","journal-title":"Nat Med"},{"key":"key20200713233149_b16-mmr-20-02-1131","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"key20200713233149_b17-mmr-20-02-1131","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s41590-017-0022-x","article-title":"Myeloid-derived suppressor cells coming of age","volume":"19","author":"Veglia","year":"2018","journal-title":"Nat Immunol"},{"key":"key20200713233149_b18-mmr-20-02-1131","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/bs.acr.2015.04.002","article-title":"Myeloid-derived suppressor cells: Critical cells driving immune suppression in the tumor microenvironment","volume":"128","author":"Parker","year":"2015","journal-title":"Adv Cancer Res"},{"key":"key20200713233149_b19-mmr-20-02-1131","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/nrc3581","article-title":"History of myeloid-derived suppressor cells","volume":"13","author":"Talmadge","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"key20200713233149_b20-mmr-20-02-1131","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.intimp.2011.02.021","article-title":"Tumor- and organ-dependent infiltration by myeloid-derived suppressor cells","volume":"11","author":"Younos","year":"2011","journal-title":"Int Immunopharmacol"},{"key":"key20200713233149_b21-mmr-20-02-1131","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/art.39441","article-title":"Elimination of granulocytic myeloid-derived suppressor cells in lupus-prone mice linked to reactive oxygen species-dependent extracellular trap formation","volume":"68","author":"Vlachou","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"key20200713233149_b22-mmr-20-02-1131","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.molimm.2018.07.016","article-title":"Myeloid-derived suppressor cells exacerbate Sj\u00f6gren's syndrome by inhibiting Th2 immune responses","volume":"101","author":"Qi","year":"2018","journal-title":"Mol Immunol"},{"key":"key20200713233149_b23-mmr-20-02-1131","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1042\/CS20160311","article-title":"Myeloid-derived suppressor cells contribute to systemic lupus erythaematosus by regulating differentiation of Th17 cells and Tregs","volume":"130","author":"Ji","year":"2016","journal-title":"Clin Sci (Lond)"},{"key":"key20200713233149_b24-mmr-20-02-1131","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1136\/annrheumdis-2014-205508","article-title":"Myeloid-derived suppressor cells have a proinflammatory role in the pathogenesis of autoimmune arthritis","volume":"75","author":"Guo","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"key20200713233149_b25-mmr-20-02-1131","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1080\/08916934.2017.1283405","article-title":"Aberrant function of myeloid-derived suppressor cells (MDSCs) in experimental colitis and in inflammatory bowel disease (IBD) immune responses","volume":"50","author":"Kontaki","year":"2017","journal-title":"Autoimmunity"},{"key":"key20200713233149_b26-mmr-20-02-1131","doi-asserted-by":"publisher","first-page":"3861","DOI":"10.4049\/jimmunol.1402689","article-title":"IL-12 promotes myeloid-derived suppressor cell recruitment and bacterial persistence during Staphylococcus aureus orthopedic implant infection","volume":"194","author":"Heim","year":"2015","journal-title":"J Immunol"},{"key":"key20200713233149_b27-mmr-20-02-1131","doi-asserted-by":"publisher","first-page":"4746","DOI":"10.1172\/JCI58814","article-title":"IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumors","volume":"121","author":"Kerkar","year":"2011","journal-title":"J Clin Invest"},{"key":"key20200713233149_b28-mmr-20-02-1131","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/j.1365-2567.2011.03429.x","article-title":"The role of interleukin-12 on modulating myeloid-derived suppressor cells, increasing overall survival and reducing metastasis","volume":"133","author":"Steding","year":"2011","journal-title":"Immunology"},{"key":"key20200713233149_b29-mmr-20-02-1131","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jaut.2007.09.003","article-title":"Desiccating environmental stress exacerbates autoimmune lacrimal keratoconjunctivitis in non-obese diabetic mice","volume":"30","author":"Yoon","year":"2008","journal-title":"J Autoimmun"},{"key":"key20200713233149_b30-mmr-20-02-1131","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jconrel.2013.07.016","article-title":"A rapamycin-binding protein polymer nanoparticle shows potent therapeutic activity in suppressing autoimmune dacryoadenitis in a mouse model of Sj\u00f6gren's syndrome","volume":"171","author":"Shah","year":"2013","journal-title":"J Control Release"},{"key":"key20200713233149_b31-mmr-20-02-1131","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1177\/154411130201300103","article-title":"Progress in understanding autoimmune exocrinopathy using the non-obese diabetic mouse: An update","volume":"13","author":"Cha","year":"2002","journal-title":"Crit Rev Oral Biol Med"},{"key":"key20200713233149_b32-mmr-20-02-1131","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1172\/JCI1230","article-title":"Male gonadal environment paradoxically promotes dacryoadenitis in nonobese diabetic mice","volume":"101","author":"Hunger","year":"1998","journal-title":"J Clin Invest"},{"key":"key20200713233149_b33-mmr-20-02-1131","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1136\/annrheumdis-2013-204584","article-title":"Th17 cells play a critical role in the development of experimental Sj\u00f6gren's syndrome","volume":"74","author":"Lin","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"key20200713233149_b34-mmr-20-02-1131","doi-asserted-by":"publisher","first-page":"26","DOI":"10.5411\/wji.v4.i1.26","article-title":"Role of myeloid-derived suppressor cells in autoimmune disease","volume":"4","author":"Crook","year":"2014","journal-title":"World J Immunol"},{"key":"key20200713233149_b35-mmr-20-02-1131","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nri1001","article-title":"Interleukin-12 and the regulation of innate resistance and adaptive immunity","volume":"3","author":"Trinchieri","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"key20200713233149_b36-mmr-20-02-1131","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1136\/annrheumdis-2017-212794","article-title":"The STAT4 SLE risk allele rs7574865[T] is associated with increased IL-12-induced IFN-\u03b3 production in T cells from patients with SLE","volume":"77","author":"Hagberg","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"key20200713233149_b37-mmr-20-02-1131","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.cyto.2016.07.015","article-title":"Anti cytokine therapy in chronic inflammatory arthritis","volume":"86","author":"Thompson","year":"2016","journal-title":"Cytokine"},{"key":"key20200713233149_b38-mmr-20-02-1131","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jns.2013.03.002","article-title":"Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination","volume":"333","author":"Rostami","year":"2013","journal-title":"J Neurol Sci"},{"key":"key20200713233149_b39-mmr-20-02-1131","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nrrheum.2013.110","article-title":"Advances in understanding the pathogenesis of primary Sj\u00f6gren's syndrome","volume":"9","author":"Nocturne","year":"2013","journal-title":"Nat Rev Rheumatol"},{"key":"key20200713233149_b40-mmr-20-02-1131","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.clim.2015.02.001","article-title":"Myeloid-derived suppressor cells are proinflammatory and regulate collagen-induced arthritis through manipulating Th17 cell differentiation","volume":"157","author":"Zhang","year":"2015","journal-title":"Clin Immunol"},{"key":"key20200713233149_b41-mmr-20-02-1131","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1053\/j.gastro.2008.06.032","article-title":"Myeloid-derived suppressor cells in inflammatory bowel disease: A new immunoregulatory pathway","volume":"135","author":"Haile","year":"2008","journal-title":"Gastroenterology"},{"key":"key20200713233149_b42-mmr-20-02-1131","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.1182\/blood-2008-07-168575","article-title":"Circulating Ly-6C+ myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating disease","volume":"113","author":"King","year":"2009","journal-title":"Blood"},{"key":"key20200713233149_b43-mmr-20-02-1131","doi-asserted-by":"publisher","first-page":"4295","DOI":"10.4049\/jimmunol.1200086","article-title":"Mouse CD11b+Gr-1+ myeloid cells can promote Th17 cell differentiation and experimental autoimmune encephalomyelitis","volume":"189","author":"Yi","year":"2012","journal-title":"J Immunol"},{"key":"key20200713233149_b44-mmr-20-02-1131","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2174\/156652309788921099","article-title":"Gene therapy using IL 12 family members in infection, auto immunity, and cancer","volume":"9","author":"Waldner","year":"2009","journal-title":"Curr Gene Ther"},{"key":"key20200713233149_b45-mmr-20-02-1131","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.cytogfr.2015.07.003","article-title":"Interleukin-12: Functional activities and implications for disease","volume":"26","author":"Zundler","year":"2015","journal-title":"Cytokine Growth Factor Rev"},{"key":"key20200713233149_b46-mmr-20-02-1131","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.2353\/ajpath.2008.080246","article-title":"Foxp3+ T-regulatory cells in Sjogren's syndrome: Correlation with the grade of the autoimmune lesion and certain adverse prognostic factors","volume":"173","author":"Christodoulou","year":"2008","journal-title":"Am J Pathol"},{"key":"key20200713233149_b47-mmr-20-02-1131","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.jaut.2005.01.015","article-title":"CD4 CD25high regulatory T cells are not impaired in patients with primary Sj\u00f6gren's syndrome","volume":"24","author":"Gottenberg","year":"2005","journal-title":"J Autoimmun"},{"key":"key20200713233149_b48-mmr-20-02-1131","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1365-2249.2009.04071.x","article-title":"Decrease of blood dendritic cells and increase of tissue-infiltrating dendritic cells are involved in the induction of Sj\u00f6gren's syndrome but not in the maintenance","volume":"159","author":"Ozaki","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"key20200713233149_b49-mmr-20-02-1131","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/labinvest.3780062","article-title":"Two different types of sialoadenitis in the NOD- and MRL\/lpr mouse models for Sj\u00f6gren's syndrome: A differential role for dendritic cells in the initiation of sialoadenitis?","volume":"80","author":"van Blokland","year":"2000","journal-title":"Lab Invest"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T00:24:35Z","timestamp":1594686275000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mmr.2019.10352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,6]]},"references-count":49,"URL":"https:\/\/doi.org\/10.3892\/mmr.2019.10352","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,6]]}}}